\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ the\\ management\\ of\\ aortitis\\ depends\\ on\\ the\\ underlying\\ cause\\.\\ the\\ initial\\ treatment\\ of\\ infectious\\ aortitis\\ is\\ intravenous\\ antibiotics\\ with\\ broad\\ antimicrobial\\ coverage\\ of\\ the\\ most\\ likely\\ pathological\\ organisms\\,\\ particularly\\ staphylococcal\\ species\\ and\\ gram\\-negative\\ rods\\.\\ surgical\\ interventions\\ may\\ be\\ necessary\\.\\ \\ immunosuppressive\\ therapy\\ such\\ as\\ oral\\ glucocorticoid\\ therapy\\ is\\ the\\ primary\\ treatment\\ for\\ inflammatory\\ aortitis\\.\\ all\\ patients\\ with\\ takayasu\\ arteritis\\ or\\ gca\\ with\\ known\\ aortic\\ involvement\\ should\\ undergo\\ periodic\\ imaging\\ for\\ the\\ development\\ of\\ complications\\ such\\ as\\ aortic\\ aneurysm\\.\\ angioplasty\\ or\\ bypass\\ grafts\\ or\\ stents\\ may\\ be\\ necessary\\ once\\ arterial\\ stenosis\\ has\\ occurred\\.\ \(0\)\
\-\ throughout\\ the\\ lower\\ thoracic\\ descending\\ aorta\\ and\\ abdominal\\ aorta\\,\\ there\\ is\\ marked\\ circumferential\\ soft\\ tissue\\ density\\.\\ this\\ does\\ not\\ appear\\ to\\ represent\\ intramural\\ hematoma\\,\\ atherosclerotic\\ plaque\\,\\ or\\ thrombus\\,\\ but\\ rather\\ thickening\\ and\\ enhancement\\ of\\ the\\ aortic\\ wall\\.\\ the\\ celiac\\,\\ superior\\ mesenteric\\,\\ inferior\\ mesenteric\\,\\ and\\ bilateral\\ renal\\ arteries\\ are\\ patent\\ and\\ without\\ significant\\ stenosis\\.\\ there\\ is\\ no\\ compression\\ of\\ the\\ major\\ abdominal\\ aorta\\ branch\\ vessels\\ by\\ the\\ circumferential\\ soft\\ tissue\\,\\ and\\ the\\ soft\\ tissue\\ does\\ not\\ appear\\ to\\ extend\\ on\\ to\\ the\\ branch\\ vessels\\.\ \(0\)\
\-\ unknown\ \(157\)\
\-\ \\â\\€\\¢\\ inflammatory\\:\ \(0\)\
\-\ \\ \\ \\ takayasu\\ arteritis\ \(0\)\
\-\ \\ \\ \\ giant\\ cell\\ arteritis\ \(0\)\
\-\ \\ \\ \\ behcet\\ disease\ \(0\)\
\-\ \\ \\ \\ cogan\\ syndrome\ \(0\)\
\-\ \\ \\ \\ others\\ \\(sle\\,\\ polyarteritis\\ nodosa\\)\ \(0\)\
\-\ \\â\\€\\¢\\ infectious\\ aortitis\ \(0\)\
\-\ \\â\\€\\¢\\ idiopathic\\ aortitis\ \(0\)\
\-\ 64\\ y\\.o\\.\\ woman\\ with\\ chest\\ pain\ \(1\)\
\-\ patient\\ developed\\ aneurysm\\ of\\ the\\ thoracic\\ aorta\\ as\\ commonaly\\ seen\\ with\\ many\\ cases\\ of\\ vasculities\\ of\\ the\\ aorta\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aortitis\\:\\ 0\\.14587207513223477\ \(0\)\
\-\ aorta\\:\\ 0\\.0742514969059321\ \(0\)\
\-\ arteritis\\:\\ 0\\.06898814827575728\ \(0\)\
\-\ takayasu\\:\\ 0\\.050011830723491815\ \(0\)\
\-\ aortic\\:\\ 0\\.04201132165135003\ \(0\)\
\-\ circumferential\\:\\ 0\\.04192657703838148\ \(0\)\
\-\ branch\\:\\ 0\\.03745638608858358\ \(0\)\
\-\ gca\\:\\ 0\\.0356903579917672\ \(0\)\
\-\ cogan\\:\\ 0\\.0356903579917672\ \(0\)\
\-\ commonaly\\:\\ 0\\.0356903579917672\ \(0\)\
\-\ vasculities\\:\\ 0\\.0356903579917672\ \(0\)\
\-\ staphylococcal\\:\\ 0\\.032884094102860535\ \(0\)\
\-\ mesenteric\\:\\ 0\\.031905434014294305\ \(0\)\
\-\ necessary\\:\\ 0\\.030648425122057187\ \(0\)\
\-\ immunosuppressive\\:\\ 0\\.030077830213953875\ \(0\)\
\-\ infectious\\:\\ 0\\.029747812692014885\ \(0\)\
\-\ gram\\-negative\\:\\ 0\\.02843627107181556\ \(0\)\
\-\ glucocorticoid\\:\\ 0\\.02843627107181556\ \(0\)\
\-\ behcet\\:\\ 0\\.02843627107181556\ \(0\)\
\-\ appear\\:\\ 0\\.0283190156285205\ \(0\)\
\-\ vessels\\:\\ 0\\.02785619446382456\ \(0\)\
\-\ aneurysm\\:\\ 0\\.027347685142051034\ \(0\)\
\-\ antimicrobial\\:\\ 0\\.027271566325047215\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.027271566325047215\ \(0\)\
\-\ stenosis\\:\\ 0\\.027104925367055603\ \(0\)\
\-\ species\\:\\ 0\\.02679471192967724\ \(0\)\
\-\ thoracic\\:\\ 0\\.02667253041379961\ \(0\)\
\-\ grafts\\:\\ 0\\.025982279964243432\ \(0\)\
\-\ nodosa\\:\\ 0\\.025982279964243432\ \(0\)\
\-\ coverage\\:\\ 0\\.025630007182908896\ \(0\)\
\-\ rods\\:\\ 0\\.025630007182908896\ \(0\)\
\-\ soft\\:\\ 0\\.025274414137573482\ \(0\)\
\-\ stents\\:\\ 0\\.024726591995401975\ \(0\)\
\-\ tissue\\:\\ 0\\.024600257349626644\ \(0\)\
\-\ inflammatory\\:\\ 0\\.023994461086575092\ \(0\)\
\-\ does\\:\\ 0\\.023608267776388716\ \(0\)\
\-\ depends\\:\\ 0\\.022996049425252425\ \(0\)\
\-\ interventions\\:\\ 0\\.022996049425252425\ \(0\)\
\-\ angioplasty\\:\\ 0\\.022199651472839248\ \(0\)\
\-\ periodic\\:\\ 0\\.022057581352145847\ \(0\)\
\-\ intramural\\:\\ 0\\.022057581352145847\ \(0\)\
\-\ such\\:\\ 0\\.02163022501895427\ \(0\)\
\-\ bypass\\:\\ 0\\.02141359473421189\ \(0\)\
\-\ celiac\\:\\ 0\\.021296236285332327\ \(0\)\
\-\ organisms\\:\\ 0\\.02096328851919074\ \(0\)\
\-\ plaque\\:\\ 0\\.02085812460662693\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.02075562335972697\ \(0\)\
\-\ sle\\:\\ 0\\.020655653268267977\ \(0\)\
\-\ others\\:\\ 0\\.02036975218643011\ \(0\)\
\-\ pathological\\:\\ 0\\.02018978553634576\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.01903256297484884\ \(0\)\
\-\ 64\\:\\ 0\\.018852774658327232\ \(0\)\
\-\ therapy\\:\\ 0\\.018499115759033305\ \(0\)\
\-\ occurred\\:\\ 0\\.018320076853514604\ \(0\)\
\-\ broad\\:\\ 0\\.017949359470820308\ \(0\)\
\-\ particularly\\:\\ 0\\.017849389379361317\ \(0\)\
\-\ once\\:\\ 0\\.017703915657798306\ \(0\)\
\-\ undergo\\:\\ 0\\.01756348829752345\ \(0\)\
\-\ thrombus\\:\\ 0\\.017472505075450336\ \(0\)\
\-\ extend\\:\\ 0\\.017339752756328916\ \(0\)\
\-\ abdominal\\:\\ 0\\.017294892616373403\ \(0\)\
\-\ intravenous\\:\\ 0\\.017169260912806135\ \(0\)\
\-\ patent\\:\\ 0\\.017045944283313387\ \(0\)\
\-\ descending\\:\\ 0\\.016887155970951927\ \(0\)\
\-\ giant\\:\\ 0\\.016660073110016525\ \(0\)\
\-\ rather\\:\\ 0\\.016445053574332527\ \(0\)\
\-\ or\\:\\ 0\\.016218991886051942\ \(0\)\
\-\ major\\:\\ 0\\.016175048009560572\ \(0\)\
\-\ idiopathic\\:\\ 0\\.015771406875054142\ \(0\)\
\-\ as\\:\\ 0\\.015699321933936774\ \(0\)\
\-\ represent\\:\\ 0\\.015194021825666119\ \(0\)\
\-\ may\\:\\ 0\\.015176747926300598\ \(0\)\
\-\ arterial\\:\\ 0\\.01514309558191365\ \(0\)\
\-\ development\\:\\ 0\\.015067887543156825\ \(0\)\
\-\ not\\:\\ 0\\.014997797632493143\ \(0\)\
\-\ underlying\\:\\ 0\\.014826829269104126\ \(0\)\
\-\ oral\\:\\ 0\\.01457725775853244\ \(0\)\
\-\ arteries\\:\\ 0\\.01432147273172462\ \(0\)\
\-\ many\\:\\ 0\\.014219487918653533\ \(0\)\
\-\ treatment\\:\\ 0\\.01400499562429868\ \(0\)\
\-\ complications\\:\\ 0\\.013709201599239098\ \(0\)\
\-\ marked\\:\\ 0\\.01350153643977533\ \(0\)\
\-\ unknown\\:\\ 0\\.01350153643977533\ \(0\)\
\-\ developed\\:\\ 0\\.013320103177468479\ \(0\)\
\-\ management\\:\\ 0\\.013054783171885187\ \(0\)\
\-\ antibiotics\\:\\ 0\\.012994803067491907\ \(0\)\
\-\ throughout\\:\\ 0\\.012950394033602942\ \(0\)\
\-\ compression\\:\\ 0\\.012950394033602942\ \(0\)\
\-\ involvement\\:\\ 0\\.012679913589586301\ \(0\)\
\-\ hematoma\\:\\ 0\\.012311606795231134\ \(0\)\
\-\ inferior\\:\\ 0\\.011738122920482036\ \(0\)\
\-\ thickening\\:\\ 0\\.011727224978515595\ \(0\)\
\-\ cause\\:\\ 0\\.011705516706688122\ \(0\)\
\-\ available\\:\\ 0\\.011630441493278531\ \(0\)\
\-\ cases\\:\\ 0\\.011525550056603774\ \(0\)\
\-\ initial\\:\\ 0\\.011463895316920275\ \(0\)\
\-\ density\\:\\ 0\\.011383122902267041\ \(0\)\
\-\ superior\\:\\ 0\\.011047545332203205\ \(0\)\
\-\ should\\:\\ 0\\.011029184380116599\ \(0\)\
\-\ \\,\\:\\ 0\\.010959921680861837\ \(0\)\
\-\ known\\:\\ 0\\.010947575240744209\ \(0\)\
\-\ be\\:\\ 0\\.010670094925861774\ \(0\)\
\-\ renal\\:\\ 0\\.01039463785205696\ \(0\)\
\-\ there\\:\\ 0\\.010297291955182095\ \(0\)\
\-\ primary\\:\\ 0\\.010248519282978529\ \(0\)\
\-\ wall\\:\\ 0\\.010020887126472656\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009985341832334819\ \(0\)\
\-\ syndrome\\:\\ 0\\.009894358610261706\ \(0\)\
\-\ all\\:\\ 0\\.009785115341827088\ \(0\)\
\-\ likely\\:\\ 0\\.00975825897139942\ \(0\)\
\-\ cell\\:\\ 0\\.009345104095471604\ \(0\)\
\-\ significant\\:\\ 0\\.009303024903053536\ \(0\)\
\-\ enhancement\\:\\ 0\\.009273233870943465\ \(0\)\
\-\ is\\:\\ 0\\.009105923536594748\ \(0\)\
\-\ patients\\:\\ 0\\.00895374331727136\ \(0\)\
\-\ bilateral\\:\\ 0\\.008396023195605036\ \(0\)\
\-\ the\\:\\ 0\\.008395705548803185\ \(0\)\
\-\ chest\\:\\ 0\\.008278255060961614\ \(0\)\
\-\ without\\:\\ 0\\.008145802292948017\ \(0\)\
\-\ imaging\\:\\ 0\\.008105562042330375\ \(0\)\
\-\ woman\\:\\ 0\\.007991509908861969\ \(0\)\
\-\ most\\:\\ 0\\.007987186808615692\ \(0\)\
\-\ lower\\:\\ 0\\.007780818094590537\ \(0\)\
\-\ but\\:\\ 0\\.007378555874629707\ \(0\)\
\-\ surgical\\:\\ 0\\.007272152915997788\ \(0\)\
\-\ seen\\:\\ 0\\.006836549048857045\ \(0\)\
\-\ has\\:\\ 0\\.006496761014146874\ \(0\)\
\-\ for\\:\\ 0\\.00590370970560903\ \(0\)\
\-\ on\\:\\ 0\\.005861465687169458\ \(0\)\
\-\ by\\:\\ 0\\.005760610944311234\ \(0\)\
\-\ disease\\:\\ 0\\.005654807859172891\ \(0\)\
\-\ to\\:\\ 0\\.00518706204586623\ \(0\)\
\-\ are\\:\\ 0\\.004716088552751424\ \(0\)\
\-\ \\:\\:\\ 0\\.004576011400771923\ \(0\)\
\-\ and\\:\\ 0\\.004372688398353484\ \(0\)\
\-\ of\\:\\ 0\\.0042450777618700235\ \(0\)\
\-\ pain\\:\\ 0\\.00422513428150095\ \(0\)\
\-\ this\\:\\ 0\\.003891243778599729\ \(0\)\
\-\ no\\:\\ 0\\.0034835795575052712\ \(0\)\
\-\ patient\\:\\ 0\\.003467983525977279\ \(0\)\
\-\ \\(\\:\\ 0\\.0029245414017970064\ \(0\)\
\-\ \\)\\:\\ 0\\.0028888165672603444\ \(0\)\
\-\ with\\:\\ 0\\.002368505588864165\ \(0\)\
\-\ \\.\\:\\ 0\\.001724673818494556\ \(0\)\
